Treatment Approaches for Therapy-Related AML, MDS Based on Mutation Profiles

In this video, Michael Heuser, MD, of the Hannover Medical School in Germany, discusses different mutational profiles of therapy-related myeloid neoplasms, such as acute myeloid leukemia (AML) and myelodysplastic syndromes, and how these genetic profiles can affect approaches to treatment.

Dr. Heuser spoke at an education session on AML at the 58^th Annual Meeting of the American Society of Hematology, held December 3–6 in San Diego, California.